Operating Lease, Right-of-Use Asset of HOOKIPA Pharma Inc. from 31 Mar 2019 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
HOOKIPA Pharma Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 31 Mar 2025.
  • HOOKIPA Pharma Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $588,000, a 88% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

HOOKIPA Pharma Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $588,000 -$4,377,000 -88% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $885,000 -$4,588,000 -84% 31 Dec 2024 10-Q 15 May 2025 2025 Q1
Q3 2024 $2,862,000 $0 0% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $5,013,000 +$1,695,000 +51% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $4,965,000 +$1,279,000 +35% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $5,473,000 +$1,467,000 +37% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $2,862,000 -$1,175,000 -29% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $3,318,000 -$1,352,000 -29% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $3,686,000 -$1,627,000 -31% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $4,006,000 -$1,667,000 -29% 31 Dec 2022 10-K 22 Mar 2024 2023 FY
Q3 2022 $4,037,000 -$628,000 -13% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $4,670,000 -$596,000 -11% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $5,313,000 -$420,000 -7.3% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $5,673,000 -$779,000 -12% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $4,665,000 -$2,073,000 -31% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $5,266,000 -$1,683,000 -24% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $5,733,000 -$1,553,000 -21% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 $6,452,000 -$1,423,000 -18% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 $6,738,000 -$1,389,000 -17% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $6,949,000 -$1,960,000 -22% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $7,286,000 -$1,634,000 -18% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $7,875,000 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q3 2019 $8,127,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $8,909,000 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 $8,920,000 31 Mar 2019 10-Q 20 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.